Skip to Content
About Us Become an Authorised Buyer Medical Partners Blog Contact Us
🌐Ship toSelect country
  1. All products
  2. Shop by Brand
  3. Restylane Volyme Lidocaine - 1 x 1,0ml
  4. Shop by Brand
Pricelist: Default Pricelist
Pricelist: Default Pricelist
Restylane Volyme Lidocaine - 1 x 1,0ml

Restylane Volyme Lidocaine - 1 x 1,0ml

Restylane Volyme is a Galderma hyaluronic acid filler built on NASHA technology, designed to replace lost fullness and volume due to ageing. It is positioned within Galderma's 'replace lost fullness and volume' product family alongside Refyne, offering structural volumising support for areas of significant age-related volume loss. For use by licensed, trained medical professionals only.

Cross-Linked Hyaluronic Acid
76.00 € 76.00 €
  • Brand
Contact Us
Terms and Conditions

Shipping: 
DHL EXPRESS SHIPPING (EU) — approx. 2-3 working days
STANDARD SHIPPING (EU) — approx. 7-10 working days
Select your delivery country in the header to check availability for your destination.
Category Fillers Brand Restylane®
SKU A0201 Share
Treatment Areas CheeksChinJawlineNoseTemples
Tags Cross-Linked Hyaluronic Acid

Restylane Volyme is a cross-linked hyaluronic acid filler from Galderma, built on XpresHAn Technology in a firmer formulation designed to lift and add volume to the mid-face and cheeks. Formulated with lidocaine for a more comfortable injection experience.

CONCENTRATION

  • Cross-linked hyaluronic acid (XpresHAn Technology)
  • Lidocaine hydrochloride 0.3%

THE PACK INCLUDES

  • 1 x 1.0ml Syringe

STORAGE CONDITIONS

  • Store between 2°C and 25°C

RESULTS & DURATION

Results typically last 12-18 months, depending on individual metabolism.

INDICATIONS

  • Loss of cheek and mid-face volume
  • Facial contouring

TREATMENT AREAS

  • Cheeks
  • Face, general

Restylane Volyme is injected into the deep dermis or subcutaneous plane using bolus or fanning technique.

Results are visible immediately, with final results assessed after 2-4 weeks.

  • Pregnancy or breastfeeding
  • People under the age of 18
  • Active infection or inflammation at the treatment site
  • Known hypersensitivity to hyaluronic acid or lidocaine
  • Patients prone to hypertrophic scarring
  • Autoimmune diseases affecting the skin